Please login to the form below

Not currently logged in
Email:
Password:

EMA elects Dr Christa Wirthumer-Hoche new vice chair

Head of the Austrian regulator succeeds Prof DrWalter Schwerdtfeger

EMA Christa Wirthumer-HocheThe European Medicine Agency's (EMA) management board has elected the head of the Austrian Medicines and Medical Devices Agency Dr Christa Wirthumer-Hoche to be its new vice chair.

Dr Wirthumer-Hoche, who will hold the position for a three-year term, succeeds Prof Dr Walter Schwerdtfeger following his retirement from the German Federal Institute for Drugs and Medical Devices.

She has been involved in the European medicines regulatory network since 1995, when Austria joined the European Union, has was a member of the Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) between 2005 and 2013.

Dr Wirthumer-Hoche is the co-chair of the recently created EU network training centre and has been a member of the EMA Management Board since October 2013.

She joined the Austrian National Institute for Quality Control of Drugs, as it was then known, in 1983, focusing initially on the assessment of quality documentation.

Between 1998 and 2005 she headed up the licensing division for medicinal products within the Unit for Pharmaceutical Affairs in the Austrian Federal Ministry of Health and Women.

Then, with the 2006 founding of the new Austrian Medicines and Medical Devices Agency, Dr Wirthumer-Hoche took up a role as head of institute for marketing authorisation and lifecycle management of medicinal products, before being appointed its head in 2013.

25th March 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics